Can a single shot lower bad cholesterol?

Verve-102 is an experimental gene-editing therapy designed to lower LDL, or bad cholesterol, by targeting the PCSK9 gene in liver cells. Unlike daily cholesterol medicines, it aims for a potentially long-lasting effect after a single treatment. Researchers are studying its safety, effectiveness and whether gene editing could transform cholesterol management.